Skip to main content
Toggle navigation
Menu
Overall search
Search ClinicalINFO
In affiliation with
HIV.gov
Search
Close
Main navigation
Home
About
Guidelines
Drug Database
Glossary
News
Resources
Contact Us
English
Toggle Dropdown
English
Español (Spanish)
Home
Search Results
Overall search
Search ClinicalINFO
Search Results
3101 – 3120
of
3979
Appendix B: Safety and Toxicity of Individual Antiretroviral Agents in Pregnancy
https://clinicalinfo.hiv.gov/guidelines/perinatal-hiv-clinical-guidelines/appendix-b-safety-and-toxicity-individual
Non-Nucleoside Reverse Transcriptase Inhibitors
https://clinicalinfo.hiv.gov/guidelines/perinatal/non-nucleoside-reverse-transcriptase-inhibitors
Tables
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/tables
Table 4. Significant Pharmacokinetic Interactions Between Drugs Used to Treat or Prevent Opportunistic Infections
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/significant-drug-interactions
Guidelines Panel Members
https://clinicalinfo.hiv.gov/guidelines/pediatric-arv/guidelines-panel-members
Archived Drugs
https://clinicalinfo.hiv.gov/guidelines/perinatal/archived-drugs
Amprenavir (Agenerase, APV)
https://clinicalinfo.hiv.gov/guidelines/perinatal/archived-drugs-amprenavir-agenerase
Cytomegalovirus Disease
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/cytomegalovirus
Limitations to Treatment Safety and Efficacy
https://clinicalinfo.hiv.gov/guidelines/adult-and-adolescent-arv/limitations-treatment-safety-and-efficacy
Adherence to the Continuum of Care
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/adherence-continuum-care
Appendix B: Mycobacterium tuberculosis
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/appendix-b-11
Considerations for Antiretroviral Use in Patients With Coinfections
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/considerations-antiretroviral-use
Tuberculosis/HIV Coinfection
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/tuberculosishiv-coinfection
Appendix A: Key to Acronyms
https://clinicalinfo.hiv.gov/guidelines/adult-and-adolescent-arv/appendix-key-acronyms
Appendix A: Drug Name Abbreviations
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/appendix-drug-name-abbreviations
Antepartum Care
https://clinicalinfo.hiv.gov/guidelines/perinatal/prepregnancy-counseling-childbearing-age
Indinavir (Crixivan, IDV)
https://clinicalinfo.hiv.gov/guidelines/perinatal/archived-drugs-indinavir-crixivan
Appendix A: Pediatric Antiretroviral Drug Information
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-pediatric-arv/appendix-pediatric-antiretroviral-drug-information
Pharmacokinetic Enhancers
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-pediatric-arv/pharmacokinetic-enhancers
Ritonavir
https://clinicalinfo.hiv.gov/guidelines/pediatric-arv/ritonavir
Pagination
First page
«
Previous page
‹
…
Page
152
Page
153
Page
154
Page
155
Current page
156
Page
157
Page
158
Page
159
Page
160
…
Next page
›
Last page
»